Výsledky vyhledávání - Gomez, Erica
- Zobrazuji výsledky 1 - 15 z 15
-
1
-
2
Exploring Molecular and Electronic Property Predictions of Reduced Graphene Oxide Nanoflakes via Density Functional Theory Autor Gómez, Erica Valencia, Ramírez Guarnizo, Nathalia A., Perea, Jose Dario, López, Alberto Sánchez, Prías-Barragán, Jhon J.
Vydáno 2022Text -
3
Tetrahydrocannabinol Reduces Hapten-Driven Mast Cell Accumulation and Persistent Tactile Sensitivity in Mouse Model of Allergen-Provoked Localized Vulvodynia Autor Boo, Beebie, Kamath, Rohit, Arriaga-Gomez, Erica, Landry, Jasmine, Emanuel, Elizabeth, Joo, Sookyong, Saldías Montivero, Marietta, Martinov, Tijana, Fife, Brian T., Chatterjea, Devavani
Vydáno 2019Text -
4
ACTR-55. TUMOR VOLUME AS A PREDICTOR OF RESPONSE TO ANTI-EGFR ADC ABT-414 Autor Gan, Hui, Seow, Aidan, Lau, Eddie, Sze-Ting, Lee, Ameratunga, Malaka, Perchyonok, Yuliya, Cao, Diana, Rigopoulos, Angela, Lee, Ho-Jin, Gomez, Erica, Maag, David, Scott, Andrew
Vydáno 2018Text -
5
ACTR-13. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION RATES OBSERVED IN SCREENING PATIENTS FOR RANDOMIZED CLINICAL TRIALS IN GLIOBLASTOMA Autor van den Bent, Martin, Roberts-Rapp, Lisa A, Ansell, Peter J, Lee, James, Looman, Jim, Bain, Earle, Ocampo, Christopher, Holen, Kyle D, Gomez, Erica J, Lassman, Andrew B
Vydáno 2017Text -
6
Repeated dermal application of the common preservative methylisothiazolinone triggers local inflammation, T cell influx, and prolonged mast cell-dependent tactile sensitivity in mi... Autor Kline, Jaclyn M., Arriaga-Gomez, Erica, Yangdon, Tenzin, Boo, Beebie, Landry, Jasmine, Saldías-Montivero, Marietta, Neamonitaki, Nefeli, Mengistu, Hanna, Silverio, Sayira, Zacheis, Hayley, Pasha, Dogukan, Martinov, Tijana, Fife, Brian T., Chatterjea, Devavani
Vydáno 2020Text -
7
Repeated Vaginal Exposures to the Common Cosmetic and Household Preservative Methylisothiazolinone Induce Persistent, Mast Cell-Dependent Genital Pain in ND4 Mice Autor Arriaga-Gomez, Erica, Kline, Jaclyn, Emanuel, Elizabeth, Neamonitaki, Nefeli, Yangdon, Tenzin, Zacheis, Hayley, Pasha, Dogukan, Lim, Jinyoung, Bush, Susan, Boo, Beebie, Mengistu, Hanna, Kinnamon, Ruby, Shields-Cutler, Robin, Wattenberg, Elizabeth, Chatterjea, Devavani
Vydáno 2019Text -
8
Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin Autor Gan, Hui K, Parakh, Sagun, Lassman, Andrew B, Seow, Aidan, Lau, Eddie, Lee, Sze Ting, Ameratunga, Malaka, Perchyonok, Yuliya, Cao, Diana, Burvenich, Ingrid J G, O’Keefe, Graeme J, Rigopoulos, Angela, Gomez, Erica, Maag, David, Scott, Andrew M
Vydáno 2021Text -
9
PATH-29. MOLECULAR DETERMINANTS ASSOCIATED WITH RESPONSE AND RESISTANCE TO DEPATUXIZUMAB MAFODOTIN (ABT-414) IN PATIENTS WITH RECURRENT GLIOBLASTOMA Autor Lassman, Andrew, Roberts-Rapp, Lisa, He, Lei, Lu, Xin, van den Bent, Martin, Papadopoulos, Kyriakos, Merrell, Ryan, Kumthekar, Priya, Reardon, David, Gomez, Erica, Fischer, JuDee, Jiang, Fang, Zha, Zheng, Bhathena, Anahita, Holen, Kyle, Ansell, Peter, Gan, Hui K, Scott, Andrew
Vydáno 2017Text -
10
ET-19 A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM) Autor Gan, Hui K., Fichtel, Lisa, Lassman, Andrew B., Merrell, Ryan, van den Bent, Martin, Kumthekar, Priya, Scott, Andrew M., Pedersen, Michelle, Gomez, Erica, Fischer, JuDee, Ames, William, Xiong, Hao, Dudley, Matt, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle, Reardon, David A.
Vydáno 2014Text -
11
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma Autor Reardon, David A., Lassman, Andrew B., van den Bent, Martin, Kumthekar, Priya, Merrell, Ryan, Scott, Andrew M., Fichtel, Lisa, Sulman, Erik P., Gomez, Erica, Fischer, JuDee, Lee, Ho-Jin, Munasinghe, Wijith, Xiong, Hao, Mandich, Helen, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle D., Gan, Hui K.
Vydáno 2017Text -
12
Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma Autor Lassman, Andrew B., Roberts-Rapp, Lisa, Sokolova, Irina, Song, Minghao, Pestova, Ekaterina, Kular, Rupinder, Mullen, Carolyn, Zha, Zheng, Lu, Xin, Gomez, Erica, Bhathena, Anahita, Maag, David, Kumthekar, Priya, Gan, Hui K., Scott, Andrew M., Guseva, Maria, Holen, Kyle D., Ansell, Peter J., van den Bent, Martin J.
Vydáno 2019Text -
13
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma Autor Gan, Hui K, Reardon, David A, Lassman, Andrew B, Merrell, Ryan, van den Bent, Martin, Butowski, Nicholas, Lwin, Zarnie, Wheeler, Helen, Fichtel, Lisa, Scott, Andrew M, Gomez, Erica J, Fischer, JuDee, Mandich, Helen, Xiong, Hao, Lee, Ho-Jin, Munasinghe, Wijith P, Roberts-Rapp, Lisa A, Ansell, Peter J, Holen, Kyle D, Kumthekar, Priya
Vydáno 2018Text -
14
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study Autor van den Bent, Martin, Gan, Hui K., Lassman, Andrew B., Kumthekar, Priya, Merrell, Ryan, Butowski, Nicholas, Lwin, Zarnie, Mikkelsen, Tom, Nabors, Louis B., Papadopoulos, Kyriakos P., Penas-Prado, Marta, Simes, John, Wheeler, Helen, Walbert, Tobias, Scott, Andrew M., Gomez, Erica, Lee, Ho-Jin, Roberts-Rapp, Lisa, Xiong, Hao, Bain, Earle, Ansell, Peter J., Holen, Kyle D., Maag, David, Reardon, David A.
Vydáno 2017Text -
15
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial Autor Lassman, Andrew B, van den Bent, Martin J, Gan, Hui K, Reardon, David A, Kumthekar, Priya, Butowski, Nicholas, Lwin, Zarnie, Mikkelsen, Tom, Nabors, Louis B, Papadopoulos, Kyriakos P, Penas-Prado, Marta, Simes, John, Wheeler, Helen, Walbert, Tobias, Scott, Andrew M, Gomez, Erica, Lee, Ho-Jin, Roberts-Rapp, Lisa, Xiong, Hao, Ansell, Peter J, Bain, Earle, Holen, Kyle D, Maag, David, Merrell, Ryan
Vydáno 2019Text